Background
Method
Study design, setting and sample
Recruitment and data collection
Ethical approval
Measures
Illness perceptions
Beliefs about cardiac rehabilitation
Quality of life
Socio-demographic and clinical characteristics
Statistical analysis
Results
Recruitment
Characteristics of the participants
Characteristics | Patients (n = 40) | Caregivers (n = 40) |
---|---|---|
Age, years (mean, range) | 62.45 (45–78) | 59.55 (36–79) |
Males | 28 (70%) | 12 (30%) |
Marital status | ||
Married | 37 (92.5) | – |
Co-habilitating | 3 (7.5%) | – |
Employment | ||
Employed | 20 (50%) | 24 (60%) |
Unemployed or retired | 20 (50%) | 16 (40%) |
Education, years (median, range) | 14.0 (7–30) | 14.7 (10–30) |
Social deprivation (SIMD) | ||
SIMD 1–2 | 10 (25%) | – |
SIMD 3–5, out of area | 30 (75%) | – |
Diagnosis | ||
STEMI | 9 (22.5%) | – |
NSTEMI | 21 (52.5%) | – |
Unstable angina | 5 (12.5%) | – |
Stable angina | 5 (12.5%) | – |
Revascularisation | ||
Thrombolysis | 2 (5%) | – |
PCI | 32 (80%) | – |
CABG | 1 (2.5%) | – |
Left ventricular ejection fraction | ||
> 50% | 21 (52.5%) | – |
30–49% (mild-moderate impairment) | 17 (42.5%) | – |
< 29% (severe impairment), or missing | 2 (5%) | – |
Cardiac history | ||
PCI | 5 (12.5%) | – |
CABG | 3 (7.5%) | – |
Myocardial infarction | 4 (10%) | – |
Co-morbid conditions | ||
Hypertension | 23 (57.5%) | – |
Diabetes mellitus | 2 (5%) | – |
Other CVD risk factors | ||
Smoking | 16 (40%) | – |
Missing data | 10 (25%) | – |
Hypercholesterolaemia | 21 (52.5%) | – |
Missing data | 2 (5%) | – |
Medications | ||
ACE/ARB | 22/3 (62.5%) | – |
Beta blocker | 29 (72.5%) | – |
Diuretics | 2 (5%) | – |
Antidepressants | 6 (15%) | – |
Differences in perceptions of illness, beliefs about cardiac rehabilitation and quality of life
Illness perceptions: | Time point | Patients Means (SD) | Caregivers Means (SD) | p-value | Beliefs about CR: | Time point | Patients Means (SD) | Caregivers Means (SD) | p-value |
---|---|---|---|---|---|---|---|---|---|
Consequences | TP1 TP2 | 4.53 (2.5) 3.28 (2.6) | 5.45 (2.8) 3.85 (3.1) | 0.095 0.297 | Necessity | TP1 TP2 | 18.65 (2.4) 18.65 (3.8) | 18.53 (2.5) 18.78 (4.2) | 0.814 0.887 |
Timeline | TP1 TP2 | 7.18 (3.4) 7.73 (3.1) | 6.65 (2.9) 7.88 (3.2) | 0.390 0.838 | Concerns exercise | TP1 TP2 | 5.85 (2.5) 5.85 (2.7) | 5.50 (2.3) 5.63 (2.3) | 0.486 0.649 |
Personal control | TP1 TP2 | 6.65 (2.1) 6.75 (2.3) | 6.38 (2.7) 6.38 (2.7) | 0.569 0.469 | Practical barriers | TP1 TP2 | 4.58 (1.9) 5.05 (2.1) | 4.38 (1.7) 4.80 (2.4) | 0.520 0.648 |
Treatment control | TP1 TP2 | 8.73 (1.5) 8.25 (1.8) | 8.85 (1.4) 8.38 (2.1) | 0.644 0.739 | Suitability | TP1 TP2 | 3.65 (1.9) 3.53 (1.5) | 3.70 (1.6) 3.85 (1.7) | 0.900 0.373 |
Identity | TP1 TP2 | 3.03 (2.4) 2.73 (2.3 | 3.98 (2.4) 3.08 (2.5) | 0.082 0.406 | Quality of life (SF-12) | Time point | Patients Means (SD) | Caregivers Means (SD) | p-value |
Illness concern | TP1 TP2 | 5.65 (2.9) 4.95 (2.9) | 7.43 (2.3) 6.33 (2.9) | 0.003** 0.010** | Physical health (PCS) | TP1 TP2 | 47.03 (8.2) 48.50 (9.5) | 53.55 (9.4) 54.20 (6.9) | 0.002** 0.001*** |
Coherence | TP1 TP2 | 8.53 (1.5) 8.23 (1.7) | 8.65 (1.8) 8.50 (1.9) | 0.677 0.501 | Mental health (MCS) | TP1 TP2 | 47.58 (8.8) 48.68 (10.1) | 44.29 (14.6) 47.14 (11.3) | 0.268 0.576 |
Emotional response | TP1 TP2 | 3.98 (2.9) 3.98 (2.9) | 5.10 (3.1) 4.78 (3.1) | 0.134 0.269 | |||||
B-IPQ (total score) | TP1 TP2 | 30.48 (11.9) 29.43 (12.8) | 34.73 (9.9) 49.15 (9.9) | 0.077 0.001*** |
Illness perceptions/beliefs about CR as predictors of quality of life in dyadic relationships
Effect | Patients | Caregivers | Effect | Patients | Caregivers | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PCS outcome | Beta | t | p | Beta | t | p | PCS outcome | Beta | t | p | Beta | t | p |
Illness perceptions | Illness perceptions | ||||||||||||
Total score: | Consequences: | ||||||||||||
Actor effect (B-IPQ) | − 0.100 | − 0.941 | 0.350 | 0.067 | 0.636 | 0.527 | Actor effect (B-IPQ) | − 0.341 | − 0.708 | 0.481 | 0.109 | 0.226 | 0.822 |
Partner effect (B-IPQ) | 0.008 | 0.066 | 0.948 | − 0.008 | − 0.067 | 0.947 | Partner effect (B-IPQ) | − 0.339 | − 0.784 | 0.435 | − 0.076 | − 0.177 | 0.860 |
Actor effect (PCS) | 0.070 | 0.431 | 0.668 | 0.171 | 1.056 | 0.294 | Actor effect (PCS) | 0.086 | 0.545 | 0.587 | 0.133 | 0.841 | 0.403 |
Partner effect (PCS) | 0.327 | 2.439 | 0.017* | 0.323 | 2.407 | 0.018* | Partner effect (PCS) | 0.344 | 2.499 | 0.015* | 0.344 | 2.502 | 0.014* |
Timeline: | Personal control: | ||||||||||||
Actor effect (B-IPQ) | − 0.004 | −0.014 | 0.989 | − 0.016 | − 0.045 | 0.964 | Actor effect (B-IPQ) | − 1.080 | − 1.912 | 0.059 | 0.634 | 1.123 | 0.265 |
Partner effect (B-IPQ) | 0.272 | 0.622 | 0.536 | 0.410 | 0.940 | 0.350 | Partner effect (B-IPQ) | 0.103 | 0.233 | 0.816 | 0.447 | 1.009 | 0.316 |
Actor effect (PCS) | 0.130 | 0.860 | 0.392 | 0.144 | 0.950 | 0.345 | Actor effect (PCS) | 0.111 | 0.754 | 0.453 | 0.139 | 0.944 | 0.348 |
Partner effect (PCS) | 0.355 | 2.578 | 0.012* | 0.358 | 2.601 | 0.011* | Partner effect (PCS) | 0.355 | 2.684 | 0.009* | 0.317 | 2.403 | 0.019* |
Treatment control: | Identity: | ||||||||||||
Actor effect (B-IPQ) | 0.610 | 0.742 | 0.460 | 0.143 | 0.174 | 0.862 | Actor effect (B-IPQ) | − 0.933 | − 1.874 | 0.065 | − 0.534 | − 1.073 | 0.286 |
Partner effect (B-IPQ) | − 0.247 | −0.274 | 0.785 | − 0.059 | − 0.066 | 0.948 | Partner effect (B-IPQ) | 0.076 | 0.145 | 0.885 | 0.125 | 0.238 | 0.813 |
Actor effect (PCS) | 0.123 | 0.807 | 0.422 | 0.140 | 0.920 | 0.360 | Actor effect (PCS) | 0.095 | 0.601 | 0.549 | 0.123 | 0.780 | 0.438 |
Partner effect (PCS) | 0.329 | 2.464 | 0.016* | 0.333 | 2.495 | 0.015* | Partner effect (PCS) | 0.364 | 2.687 | 0.009* | 0.379 | 2.792 | 0.007* |
Illness concern: | Coherence: | ||||||||||||
Actor effect (B-IPQ) | 0.282 | 0.722 | 0.473 | −0.750 | − 1.913 | 0.059 | Actor effect (B-IPQ) | − 1.612 | − 2.011 | 0.048* | 0.060 | 0.076 | 0.940 |
Partner effect (B-IPQ) | − 0.241 | − 0.450 | 0.654 | 0.158 | 0.295 | 0.769 | Partner effect (B-IPQ) | − 0.463 | − 0.638 | 0.525 | 0.277 | 0.382 | 0.703 |
Actor effect (PCS) | 0.144 | 0.911 | 0.365 | 0.088 | 0.559 | 0.578 | Actor effect (PCS) | 0.100 | 0.675 | 0.502 | 0.127 | 0.856 | 0.395 |
Partner effect (PCS) | 0.361 | 2.779 | 0.007* | 0.304 | 2.343 | 0.022* | Partner effect (PCS) | 0.306 | 2 .293 | 0.024* | 0.329 | 2.468 | 0.016* |
Emotional response: | |||||||||||||
Actor effect (B-IPQ) | 0.123 | 0.307 | 0.759 | −0.602 | −1.498 | 0.138 | |||||||
Partner effect (B-IPQ) | −0.116 | − 0.282 | 0.778 | − 0.326 | − 0.794 | 0.429 | |||||||
Actor effect (PCS) | 0.072 | 0.467 | 0.641 | 0.138 | 0.871 | 0.386 | |||||||
Partner effect (PCS) | 0.350 | 2.674 | 0.009* | 0.306 | 2.337 | 0.022* | |||||||
Beliefs about CR | Beliefs about CR | ||||||||||||
Necessity: | Exercise concern: | ||||||||||||
Actor effect (BCR-Q) | − 0.256 | − 0.487 | 0.628 | − 0.197 | −0.375 | 0.709 | Actor effect (BCR-Q) | − 0.174 | − 0.306 | 0.761 | 0.392 | 0.688 | 0.494 |
Partner effect (BCR-Q) | 0.057 | 0.111 | 0.912 | − 0.100 | − 0.195 | 0.845 | Partner effect BCR-Q) | − 0.346 | − 0.584 | 0.561 | − 0.773 | − 1.302 | 0.197 |
Actor effect (PCS) | 0.118 | 0.774 | 0.441 | 0.135 | 0.887 | 0.378 | Actor effect (PCS) | 0.020 | 0.128 | 0.898 | 0.116 | 0.716 | 0.476 |
Partner effect (PCS) | 0.324 | 2.447 | 0.017* | 0.330 | 2.495 | 0.015* | Partner effect (PCS) | 0.286 | 1.974 | 0.052 | 0.370 | 2.551 | 0.013* |
Practical barriers: | Perceived suitability: | ||||||||||||
Actor effect (BCR-Q) | −1.295 | −2.156 | 0.034* | − 0.065 | − 0.109 | 0.914 | Actor effect (BCR-Q) | − 0.130 | − 0.212 | 0.833 | − 0.614 | − 0.996 | 0.322 |
Partner effect (BCR-Q) | −0.433 | − 0.558 | 0.578 | 0.873 | 1.124 | 0.264 | Partner effect (BCR-Q) | − 0.020 | − 0.027 | 0.978 | −0.989 | − 1.307 | 0.195 |
Actor effect (PCS) | 0.181 | 1.196 | 0.235 | 0.122 | 0.809 | 0.421 | Actor effect (PCS) | 0.113 | 0.754 | 0.453 | 0.146 | 0.974 | 0.333 |
Partner effect (PCS) | 0.306 | 2.332 | 0.022* | 0.312 | 2.376 | 0.020* | Partner effect (PCS) | 0.263 | 1.945 | 0.055 | 0.303 | 2.238 | 0.028* |
Effect | Patients | Caregivers | Effect | Patients | Caregivers | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCS outcome | Beta | t | p | Beta | t | p | MCS outcome | Beta | t | p | Beta | t | p |
Illness perceptions | Illness perceptions | ||||||||||||
Total score: | Consequences: | ||||||||||||
Actor effect (B-IPQ) | −0.105 | −0.837 | 0.405 | −0.139 | −1.104 | 0.273 | Actor effect (B-IPQ) | 1.030 | 1.987 | 0.050 | 1.078 | 2.082 | 0.041* |
Partner effect (B-IPQ) | −0.255 | −1.834 | 0.070 | −0.103 | − 0.745 | 0.459 | Partner effect (B-IPQ) | −0.338 | − 0.685 | 0.495 | −0.681 | −1.337 | 0.172 |
Actor effect (MCS) | 0.737 | 4.428 | < 0.001** | − 0.284 | − 1.708 | 0.092 | Actor effect (MCS) | 0.871 | 5.550 | < 0.001** | −0.140 | − 0.892 | 0.375 |
Partner effect (MCS) | 0.377 | 4.103 | < 0.001** | −0.143 | − 1.553 | 0.124 | Partner effect (MCS) | 0.453 | 5.006 | < 0.001** | −0.093 | −1.027 | 0.308 |
Timeline: | Personal control: | ||||||||||||
Actor effect (B-IPQ) | −0.129 | −0.319 | 0.750 | 0.086 | 0.212 | 0.832 | Actor effect (B-IPQ) | 1.288 | 1.880 | 0.064 | 0.558 | 0.815 | 0.418 |
Partner effect (B-IPQ) | −1.010 | −2.044 | 0.044* | − 0.917 | − 1.857 | 0.067 | Partner effect (B-IPQ) | 0.464 | 0.909 | 0.366 | 0.258 | 0.507 | 0.614 |
Actor effect (MCS) | 0.744 | 4.863 | < 0.001** | − 0.228 | − 1.494 | 0.137 | Actor effect (MCS) | 0.884 | 5.690 | < 0.001** | − 0.115 | − 0.745 | 0.458 |
Partner effect (MCS) | 0.485 | 5.076 | < 0.001** | − 0.644 | − 0.674 | 0.502 | Partner effect (MCS) | 0.376 | 3.885 | < 0.001** | − 0.187 | − 1.935 | 0.057 |
Treatment control: | Identity: | ||||||||||||
Actor effect (B-IPQ) | 1.409 | 1.675 | 0.098 | 3.293 | 3.914 | < 0.001** | Actor effect (B-IPQ) | −0.788 | − 1.380 | 0.171 | − 1.087 | − 1.902 | 0.061 |
Partner effect (B-IPQ) | 0.812 | 0.872 | 0.386 | − 0.655 | − 0.704 | 0.483 | Partner effect (B-IPQ) | − 0.167 | − 0.304 | 0.762 | − 0.112 | − 0.204 | 0.839 |
Actor effect (MCS) | 0.818 | 5.923 | < 0.001** | − 0.134 | − 0.974 | 0.333 | Actor effect (MCS) | 0.852 | 5.383 | < 0.001** | − 0.109 | − 0691 | 0.492 |
Partner effect (MCS) | 0.386 | 4.591 | < 0.001** | − 0.144 | − 1.719 | 0.089 | Partner effect (MCS) | 0.414 | 4.549 | < 0.001** | − 0.126 | − 1.338 | 0.169 |
Illness concern: | Coherence: | ||||||||||||
Actor effect (B-IPQ) | − 0.973 | − 2.164 | 0.034* | −0.238 | −0.530 | 0.597 | Actor effect (B-IPQ) | 0.048 | 0.052 | 0.959 | 1.812 | 1.958 | 0.054 |
Partner effect (B-IPQ) | − 1.356 | − 2.360 | 0.021* | − 0.236 | − 0.412 | 0.682 | Partner effect (B-IPQ) | 0.248 | 0.271 | 0.787 | 0.222 | 0.242 | 0.809 |
Actor effect (MCS) | 0.802 | 5.474 | < 0.011* | − 0.167 | − 1.142 | 0.257 | Actor effect (MCS) | 0.827 | 5.235 | < 0.001** | − 0.124 | − 0.787 | 0.434 |
Partner effect (MCS) | 0.391 | 4.232 | < 0.001** | − 0.084 | − 0.919 | 0.361 | Partner effect (MCS) | 0.374 | 3.584 | < 0.001** | − 0.136 | − 1.310 | 0.194 |
Emotional response: | |||||||||||||
Actor effect (B-IPQ) | −1.278 | − 2.834 | 0.006** | −0.876 | − 1.944 | 0.055 | |||||||
Partner effect (B-IPQ) | 0.100 | − 0.229 | 0.820 | − 0.409 | − 0.932 | 0.354 | |||||||
Actor effect (MCS) | 0.737 | 4.845 | 0.001** | − 0.197 | − 1.298 | 0.198 | |||||||
Partner effect (MCS) | 0.447 | 5.016 | < 0.001** | − 0.084 | − 0.951 | 0.344 | |||||||
Beliefs about CR | Beliefs about CR | ||||||||||||
Necessity: | Exercise concern: | ||||||||||||
Actor effect (BCR-Q) | −0.655 | −1.066 | 0.290 | 1.127 | 1.833 | 0.071 | Actor effect (BCR-Q) | −0.809 | −1.212 | 0.229 | 0.811 | 1.214 | 0.228 |
Partner effect (BCR-Q) | 0.295 | 0.512 | 0.610 | 0.282 | 0.489 | 0.626 | Partner effect BCR-Q) | −0.674 | −1.006 | 0.317 | −0.427 | − 0.638 | 0.525 |
Actor effect (MCS) | 0.770 | 4.864 | < 0.001** | − 0.054 | −0.345 | 0.731 | Actor effect (MCS) | 0.719 | 4.158 | < 0.001** | − 0.056 | −0.327 | 0.745 |
Partner effect (MCS) | − 0.116 | − 1.279 | 0.205 | 0.413 | 4.545 | < 0.001** | Partner effect (MCS) | −0.117 | − 1.248 | 0.216 | 0.389 | 4.133 | < 0.001** |
Practical barriers: | Perceived suitability: | ||||||||||||
Actor effect (BCR-Q) | −1.150 | −1.575 | 0.119 | −0.464 | −0.636 | 0.527 | Actor effect (BCR-Q) | − 0.184 | −0.255 | 0.800 | −0.108 | − 0.180 | 0.881 |
Partner effect BCR-Q) | −1.649 | − 1.907 | 0.060 | −0.385 | − 0.446 | 0.657 | Partner effect (BCR-Q) | −0.267 | − 0.293 | 0.770 | −0.016 | − 0.018 | 0.986 |
Actor effect (MCS) | 0.753 | 4.704 | < 0.001** | − 0.141 | −0.882 | 0.380 | Actor effect (MCS) | 0.812 | 5.140 | < 0.001** | − 0.166 | −1.052 | 0.296 |
Partner effect (MCS) | −0.886 | − 0.963 | 0.338 | 0.442 | 4.802 | < 0.001** | Partner effect (MCS) | −0.118 | − 1.168 | 0.247 | 0.432 | 4.265 | < 0.001** |